Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-05-15

Identification, presentation and delivery of epitopes for development of novel vaccine for cytomegalovirus infections

Objective

The EPI-PEP-VAC consortium will use cutting-edge research and the most advanced technologies to elucidate the structural, biochemical and cellular basis of the immune response to exogenously delivered peptide epitopes, with the central objective of defining basic rules for the selection and optimisation of peptide vaccine candidates. The research will be focused on a pathogen of major health and socio-economical importance in the EU, namely human cytomegalovirus (HCMV). Novel strategies, technologies and read-out assays will be developed for peptide definition, modelling and screening to achieve optimal peptide performance. Animal models and ex-vivo models for follow-up will be developed and used for establishment of diagnostic tools and to optimise delivery system and immunization route of peptide vaccines.

Call for proposal

Data not available

Coordinator

WEIZMANN INSTITUTE OF SCIENCE
EU contribution
No data
Address
Herzel Street 2
76100 REHOVOT
Israel

See on map

Total cost
No data

Participants (8)